Skip to main content
SpringerLink
Log in

Should we ban B6 supplementation of INH therapy in childhood tuberculosis?

  • Annotation
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Conclusion

INH-vitamin B6 combinations should therefore be banned, and manufacturers should be requested to withdraw such products from the market. Physicians are also requested not to prescribe drugs containing INH with B6.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Speek William T. Tuberculosis. In: Behrman RE, Vaughan VC.Nelson's Text Book of Pediatrics. 13th ed. Philadelphia: W. B. Saunders Company, 1987: 629–638.

    Google Scholar 

  2. Citron KM, Darbyshire JH, Ormorod LP. Chemotherapy and management of tuberculosis in the United Kingdom: Recommendations of the Joint Tuberculosis Committee of the British Thoracic Society.Thorax 1990; 45: 403–404.

    Article  Google Scholar 

  3. Barness LA. Pyridoxins (Vitamin B6) deficiency. In: Behrman RE, Kliegman RM, Nelson WE, Vaughan VC, eds.Nelson's Textbook of Pediatrics, 14th ed. Philadelphia: WB Saunders Company, 1982: 138–139.

    Google Scholar 

  4. Laurence DR, Bennett PN.Mycobacterial Infections. Clinical Pharmacology, 6th ed. Edinburgh: ELBS/Churchill Livingstone, 1987: 253–259.

    Google Scholar 

  5. Mandell GL, Sande MA. Drugs used in the chemotherapy of Tuberculosis and Leprosy. In: Gilman AG, Goodman LS, Rall TW, Murad F, eds.The Pharmacological Basis of Therapeutics, 7th ed. New York: Macmillan Publishing Co., 1985: 1199–1218.

    Google Scholar 

  6. Reed MD, Blumer JL. Clinical pharmacology of antitubercular drugs.Pediatr Clin North Am, 1983; 30: 177–193.

    PubMed  CAS  Google Scholar 

  7. Snider DE, Rieder HL, Combs D et al. Tuberculosis in children.Pediatr Infect Dis 1988; 7: 271–278.

    Article  Google Scholar 

  8. Starke JR. Modern approach to the diagnosis and treatment of tuberculosis in children.Pediatr Clin North Am 1988; 35: 441–464.

    PubMed  CAS  Google Scholar 

  9. Seth V. Isoniazid—The pivot of chemotherapy in tuberculosis: Editorial.Indian Pediatr, 1990; 27: 119–123.

    PubMed  CAS  Google Scholar 

  10. International Union against Tuberculosis and Lung Disease. Anti-tuberculosis regimes of chemotherapy. Recommendations from the Committee on Treatment of the International Union against Tuberculous and Lung Disease.Bull Int Union Tuberc Lung Dis, 1988; 63: 60–64.

    Google Scholar 

  11. Mathur GP, Kushwaha KP. Vitamin A deficiency.Indian Pediatr, 1987; 24: 573–580.

    PubMed  CAS  Google Scholar 

  12. Gulhati CM. MIMS India.Monthly Index of Medical Specialities. 1992; 12: 156–163.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, G.S.V.M. Medical College, 208002, Kanpur

    G. P. Mathur, S. Mathur & S. Rastogi

Authors
  1. G. P. Mathur
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Mathur
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Rastogi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mathur, G.P., Mathur, S. & Rastogi, S. Should we ban B6 supplementation of INH therapy in childhood tuberculosis?. Indian J Pediatr 60, 717–719 (1993). https://doi.org/10.1007/BF02751037

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02751037

Keywords

Search

Navigation